Regulatory Strategy & Compliance

Regulation (EU) 2017/746 changed the rules for in vitro diagnostics in Europe. Most products now need a notified body, a performance evaluation that stands up to scrutiny, and a quality system that supports both. Dolmen Diagnostics helps companies understand exactly where they stand.

Our Approach

What We Do

IVDR readiness assessment

A structured review of your products, technical documentation and quality system against IVDR requirements, giving you a clear picture of classification, conformity assessment route, gaps and priorities.

Remediation and implementation

Closing the gaps: technical documentation, performance evaluation planning, post-market surveillance, and the ISO 13485 quality system elements that IVDR depends on. We plan the work and, where needed, do it with your team.

Regulatory strategy

The right route for the product and the business — classification, notified body selection and interaction, the sequence of markets, and how the evidence generated for one submission can serve the next.

Submission support — IVDR, FDA, WHO-PQ

Preparation, review and coordination of submissions across regions, drawing on programme experience with products that have gone through IVDR approval and WHO Prequalification.

Technical due diligence

Independent assessment of a diagnostic technology, product or company for investment, licensing or acquisition: regulatory status, technical maturity, quality system and the realistic path to market.

Who this is for

  • Manufacturers with legacy CE-marked products that must transition to IVDR before the relevant deadlines.

  • Developers bringing a new IVD to the market for the first time.

  • Companies extending a product to other markets and needing a coordinated strategy across IVDR, FDA and WHO Prequalification.

  • Investors and acquirers who need an independent view of a diagnostic technology or company’s regulatory position.

How an engagement runs

Most IVDR work starts with an assessment of two to six weeks that produces a written gap report and a prioritised plan. From there, clients choose to implement the plan themselves with periodic review, to have us deliver defined parts of it, or to have us lead the programme through to submission.

Each option is scoped and priced in advance. IVDR compliance rests on the quality system and on design control.

Where those need attention we address them as part of the same programme.

Regulatory Strategy & Compliance

FAQs

Does IVDR apply to our product?

If you place an in vitro diagnostic on the EU market, yes — including products previously self-declared under the IVD Directive, software that meets the IVD definition, and many products that were considered low risk under the old rules. The first task is classification under the IVDR rules, which determines the conformity assessment route and how much notified body involvement you need.

We have legacy CE-marked products. How much time do we have?

What does an IVDR readiness assessment produce?

Can you support FDA and WHO Prequalification as well?

Do you deal with the notified body on our behalf?

Can you chair our design reviews?

When should design control start?

We already have a partially complete DHF. Can it be rescued?

How does design control relate to ISO 14971 risk management?

Our development partner does most of the design work. Who owns design control?

Our Experience

Our Experience

Our Experience

Get in touch

Find out where you stand under IVDR

Tell us about your products and where the programme is. We will suggest a proportionate first step — usually a readiness assessment — and say clearly what it will involve.

Get in touch

Find out where you stand under IVDR

Tell us about your products and where the programme is. We will suggest a proportionate first step — usually a readiness assessment — and say clearly what it will involve.

Get in touch

Find out where you stand under IVDR

Tell us about your products and where the programme is. We will suggest a proportionate first step — usually a readiness assessment — and say clearly what it will involve.

Independent in vitro diagnostic consultancy

Europe, North America & Asia

© Dolmen Diagnostics 2026. All rights reserved.

Independent in vitro diagnostic consultancy

Europe, North America & Asia

© Dolmen Diagnostics 2026. All rights reserved.

Independent in vitro diagnostic consultancy

Europe, North America & Asia

© Dolmen Diagnostics 2026. All rights reserved.